| Sep 15, 2023 |
Sep 19, 2023 |
Enveric Biosciences, Inc.
|
Director |
Buy |
90.0
|
+1,000
|
100.00%
|
✗
|
$2.1K |
| Nov 19, 2021 |
Nov 23, 2021 |
Theravance Biopharma, Inc.
|
SVP, CHIEF BUSINESS OFFICER |
Sell |
48.8
|
-3,779
|
-0.87%
|
✗
|
$31.6K |
| Aug 20, 2021 |
Aug 24, 2021 |
Theravance Biopharma, Inc.
|
SVP, Chief Business Officer |
Sell |
45.0
|
-3,779
|
-0.86%
|
✗
|
$53.1K |
| May 20, 2021 |
May 24, 2021 |
Theravance Biopharma, Inc.
|
SVP, Chief Business Officer |
Sell |
32.5
|
-3,779
|
-0.86%
|
✗
|
$67.3K |
| Feb 20, 2021 |
Feb 23, 2021 |
Theravance Biopharma, Inc.
|
SVP, Chief Business Officer |
Sell |
20.0
|
-26,961
|
-5.78%
|
✗
|
$506.6K |
| Nov 20, 2020 |
Nov 24, 2020 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
22.5
|
-4,214
|
-1.04%
|
✗
|
$72.5K |
| Aug 20, 2020 |
Aug 24, 2020 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
22.5
|
-4,214
|
-1.03%
|
✗
|
$76.8K |
| May 20, 2020 |
May 22, 2020 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
22.5
|
-4,214
|
-1.02%
|
✗
|
$112.4K |
| Feb 20, 2020 |
Feb 24, 2020 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
20.0
|
-24,392
|
-5.58%
|
✗
|
$631.8K |
| Nov 20, 2019 |
Nov 22, 2019 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
36.3
|
-2,447
|
-0.76%
|
✗
|
$43.1K |
| Aug 20, 2019 |
Aug 22, 2019 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
32.5
|
-2,335
|
-0.72%
|
✗
|
$50.2K |
| May 20, 2019 |
May 22, 2019 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
43.8
|
-1,604
|
-0.49%
|
✗
|
$31.8K |
| Feb 20, 2019 |
Feb 22, 2019 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
22.5
|
-4,919
|
-1.50%
|
✗
|
$132.8K |
| Nov 20, 2018 |
Nov 21, 2018 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
22.5
|
-5,735
|
-2.58%
|
✗
|
$142.2K |
| Aug 20, 2018 |
Aug 22, 2018 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
22.5
|
-5,735
|
-2.52%
|
✗
|
$154.6K |
| May 20, 2018 |
May 22, 2018 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
20.0
|
-18,424
|
-7.48%
|
✗
|
$447.9K |
| Feb 20, 2018 |
Feb 22, 2018 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
22.5
|
-4,741
|
-2.19%
|
✗
|
$137.9K |
| Nov 20, 2017 |
Nov 22, 2017 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
22.5
|
-5,820
|
-2.73%
|
✗
|
$166.3K |
| Aug 21, 2017 |
Aug 23, 2017 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Buy |
82.5
|
+4,000
|
1.91%
|
✗
|
$105.4K |
| Aug 20, 2017 |
Aug 22, 2017 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
22.5
|
-5,820
|
-2.71%
|
✗
|
$159.5K |
| May 20, 2017 |
May 23, 2017 |
Theravance Biopharma, Inc.
|
SVP, Chief Comm Ops Officer |
Sell |
22.5
|
-5,820
|
-2.64%
|
✗
|
$214.4K |
| Feb 20, 2017 |
Feb 22, 2017 |
Theravance Biopharma, Inc.
|
SVP Global Head Acute Care Bus |
Sell |
20.0
|
-8,762
|
-3.85%
|
✗
|
$296K |
| Feb 20, 2016 |
Feb 23, 2016 |
Theravance Biopharma, Inc.
|
Sr. VP, Operations |
Sell |
22.5
|
-10,830
|
-7.85%
|
✗
|
$169.5K |